MDXG Q1 2022 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$684M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$59M-1.8% YoY

Gross Profit

$49M83.1% margin

Operating Income

-$9M-15.8% margin

Net Income

-$10M-17.8% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

-12.6%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$174M

Total Liabilities

$89M

Stockholders' Equity

$85M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$59M	$60M	-1.8%
Gross Profit	$49M	$50M	-2.7%
Operating Income	-$9M	-$7M	-35.7%
Net Income	-$10M	-$8M	-25.1%

Revenue Segments

Health Care

$58M50%

Advanced Wound Care, Tissue And Other

$53M45%

Advanced Wound Care, Umbilical Cord-Derived

$6M5%

Section 351

$400,0000%

Product and Service, Other

$68,0000%